SOSV

Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

Hugh Bowen

Associate

Shawn Broderick

Venture Partner

Stephen Chambers

General Partner

Navin Danapal

Director, South East Asia

Cyril Ebersweiler

General Partner

Hiruy Ephrem

Analyst

Sheng Ge

Partner

Weichang Ge

Analyst

TR Harrington

Partner

Bradford Higgins JD

Venture Partner

Mohan S. Iyer

General Partner

Benjamin Joffe

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Yuan-Ting Meng

Analyst

Paul Monaghan

Principal

Brian Murphy

Finance Director

Sean O'Sullivan

Managing Partner

Oscar Ramos

General Partner

Eric Ramsay

Analyst

Susan Schofer Ph.D

Partner

Parikshit Sharma

Principal

Sabriya Stukes Ph.D

Partner

Duncan Turner

General Partner

Pae Wu

General Partner

Past deals in Big Data

Gatehouse Bio

Convertible Note in 2024
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Bloomlife

Series B in 2024
Bloomlife is a pioneering company in maternal health, leveraging connected devices and cloud-based data analytics to enhance access to care for expectant mothers. Its innovative solution enables obstetricians to more efficiently screen and manage pregnancy complications, empowering women and reducing geographical barriers.

Gatehouse Bio

Convertible Note in 2023
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

BiomeSense

Seed Round in 2023
BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

Gatehouse Bio

Seed Round in 2022
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

FreeD Group

Series B in 2022
FreeD Group is a technology company based in Lai Chi Kok, Hong Kong, founded in 2015. It specializes in providing a text-based virtual assistant service that offers travel information and concierge services for travelers in Korea and Japan. The company facilitates various travel-related activities, including flight and hotel bookings, trip planning, restaurant reservations, translation, and transportation services, all accessible through popular messaging platforms like WhatsApp and Facebook Messenger. Additionally, FreeD Group develops AI-enabled solutions that enhance customer engagement, retention, and monetization for businesses. By utilizing advanced technologies such as Artificial Intelligence, Big Data, and Machine Learning, the company aims to create innovative, data-driven interactions between consumers and brands. Its partnerships with notable companies, including China Mobile and Samsung, further bolster its market presence.

Gatehouse Bio

Convertible Note in 2022
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

InfiniteUp

Seed Round in 2022
Founded in 2020, InfiniteUp is a Canadian AI startup based in Nanaimo, British Columbia. It empowers small and medium-sized enterprises (SMEs) through its flagship platform, DOER Business, an all-in-one AI-powered virtual business partner offering enterprise-grade productivity tools at affordable prices. The platform includes features such as AI-driven strategic briefings, automated task management, intelligent sales recommendations, digital employee twins, a Digital COO, CEO Daily Briefing, voice command capabilities, CRM tools, and localized support.

InfiniteUp

Convertible Note in 2022
Founded in 2020, InfiniteUp is a Canadian AI startup based in Nanaimo, British Columbia. It empowers small and medium-sized enterprises (SMEs) through its flagship platform, DOER Business, an all-in-one AI-powered virtual business partner offering enterprise-grade productivity tools at affordable prices. The platform includes features such as AI-driven strategic briefings, automated task management, intelligent sales recommendations, digital employee twins, a Digital COO, CEO Daily Briefing, voice command capabilities, CRM tools, and localized support.

Inso Biosciences

Convertible Note in 2022
Inso Biosciences is an early-stage biotechnology company that develops microfluidic hardware platforms for genomic sample handling. The company's patented microfluidic technology enables high-efficiency processing of cellular material and the separation and isolation of cellular components, supporting genomic analysis and DNA sequencing workflows. Its platform aims to improve long-read DNA extraction, multiomic sample processing, and pathogen surveillance, enabling healthcare and biotech organizations to perform biological sample preparation with greater efficiency and accuracy.

Gatehouse Bio

Seed Round in 2021
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Synthace

Series C in 2021
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Dataforge.ai

Seed Round in 2021
Dataforge.ai specializes in data annotation services for artificial intelligence and machine learning applications. The company offers a platform that facilitates the training of AI models through precise image annotation, ensuring high accuracy while maintaining low costs. By leveraging machine learning technology, Dataforge.ai assists AI teams in addressing various data challenges, including storage, collection, cleaning, and labeling of data. This comprehensive approach enables clients to expedite their processes and enhance operational efficiency.

Dataforge.ai

Convertible Note in 2021
Dataforge.ai specializes in data annotation services for artificial intelligence and machine learning applications. The company offers a platform that facilitates the training of AI models through precise image annotation, ensuring high accuracy while maintaining low costs. By leveraging machine learning technology, Dataforge.ai assists AI teams in addressing various data challenges, including storage, collection, cleaning, and labeling of data. This comprehensive approach enables clients to expedite their processes and enhance operational efficiency.

BiomeSense

Convertible Note in 2021
BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

Genetsis G-Commerce

Seed Round in 2021
Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Synthace

Convertible Note in 2021
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Journey Foods

Convertible Note in 2021
Journey Foods is a technology company that empowers food businesses with AI-driven software. Its platform optimizes product development by providing real-time ingredient data, supply chain insights, and collaborative tools. This enables manufacturers to streamline operations, enhance traceability, and improve decision-making.

Gatehouse Bio

Funding Round in 2021
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Gatehouse Bio

Seed Round in 2020
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

BiomeSense

Convertible Note in 2020
BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

Lootcakes

Seed Round in 2020
Lootcakes Inc. is a New York-based company founded in 2012 that provides an online platform focused on gaming data, particularly for free-to-play games. The platform allows players to consolidate their gaming activity and social engagement across different platforms. By utilizing in-game purchasing and social data, Lootcakes connects high-value players—those who spend money and engage socially with others—to game publishers. This connection is essential as game publishers increasingly rely on these players, who drive revenue and attract new users through their social interactions. Lootcakes aims to empower gamers by helping them unlock the value of their game activity data, enabling them to benefit from their influence within the gaming community.

CITYDATA.ai

Seed Round in 2020
CITYDATA.ai is a geospatial AI company that simulates the presence and movement of people across cities worldwide by building mobility digital replicas to quantify how many people are present and how they move. By aggregating location intelligence from public and private sources, it enables cities and businesses to gain actionable insights for planning and operations. The platform supports resident engagement through mobile apps and chatbots and offers a suite of data and tooling products, including CITYSIM, CITYFLOW, CITYPARKS, CITYCOUNT, CITYOPS, CITYSURVEY, CITYCHAT, and CITYSDK, to support city planning, mobility analysis, park management, survey collection, and field workforce productivity.

Genetsis G-Commerce

Seed Round in 2020
Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Synthace

Venture Round in 2020
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

FreeD Group

Series A in 2019
FreeD Group is a technology company based in Lai Chi Kok, Hong Kong, founded in 2015. It specializes in providing a text-based virtual assistant service that offers travel information and concierge services for travelers in Korea and Japan. The company facilitates various travel-related activities, including flight and hotel bookings, trip planning, restaurant reservations, translation, and transportation services, all accessible through popular messaging platforms like WhatsApp and Facebook Messenger. Additionally, FreeD Group develops AI-enabled solutions that enhance customer engagement, retention, and monetization for businesses. By utilizing advanced technologies such as Artificial Intelligence, Big Data, and Machine Learning, the company aims to create innovative, data-driven interactions between consumers and brands. Its partnerships with notable companies, including China Mobile and Samsung, further bolster its market presence.

Journey Foods

Seed Round in 2019
Journey Foods is a technology company that empowers food businesses with AI-driven software. Its platform optimizes product development by providing real-time ingredient data, supply chain insights, and collaborative tools. This enables manufacturers to streamline operations, enhance traceability, and improve decision-making.

BiomeSense

Seed Round in 2019
BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

BiomeSense

Seed Round in 2019
BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

Synthace

Series B in 2018
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

AWB Health

Seed Round in 2018
AWB Health, founded in 2012, is a leading workplace wellness company that offers a comprehensive digital platform focused on nutrition, medical care, fitness, emotional well-being, and environmental health. The company aims to help employees develop healthy work-life habits through goal setting and personalized health reports generated from health risk assessments. In addition to its online offerings, AWB Health organizes various engaging offline events to further promote wellness. The platform provides a range of services, including health risk assessments, customized health programs, nutritional advice, and responses to health-related inquiries, enabling users to maintain their fitness and health effectively. AWB Health also generates group health reports using big data analytics, which assist companies in designing effective wellness programs that enhance employee engagement and productivity. The company serves a diverse clientele, including several Fortune 500 companies such as Disney, Roche, and Adidas.

Quartolio

Seed Round in 2018
Quartolio is an AI-powered platform that enables researchers to connect, discover, and manage scientific information. The company provides an autonomous insight discovery solution that analyzes millions of scientific documents in real time and an insight automation platform that synthesizes knowledge from scientific big data in real time. Its platform supports research informatics to streamline cross-discipline discovery in the cloud, helping clients accelerate research by linking scientific articles, clinical trials, and patents through natural language processing.

Robin8

Venture Round in 2018
Robin8 is an AI-powered social and content marketing platform that simplifies PR outreach. It curates a database of influencers using machine learning and big data, personalizing results based on user preferences.

LotaData

Seed Round in 2018
Founded in 2014, LotaData specializes in developing mobile location insights and predictive analytics solutions. Its platform analyzes public and private data to provide deep insights about city facilities usage, community demographics, and attendance for events and activities. Serving enterprise businesses, smart cities, and other stakeholders globally, LotaData operates from offices in San Francisco, London, and Porto Alegre.

Synthace

Series A in 2018
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

AWB Health

Seed Round in 2018
AWB Health, founded in 2012, is a leading workplace wellness company that offers a comprehensive digital platform focused on nutrition, medical care, fitness, emotional well-being, and environmental health. The company aims to help employees develop healthy work-life habits through goal setting and personalized health reports generated from health risk assessments. In addition to its online offerings, AWB Health organizes various engaging offline events to further promote wellness. The platform provides a range of services, including health risk assessments, customized health programs, nutritional advice, and responses to health-related inquiries, enabling users to maintain their fitness and health effectively. AWB Health also generates group health reports using big data analytics, which assist companies in designing effective wellness programs that enhance employee engagement and productivity. The company serves a diverse clientele, including several Fortune 500 companies such as Disney, Roche, and Adidas.

Bloomlife

Series A in 2017
Bloomlife is a pioneering company in maternal health, leveraging connected devices and cloud-based data analytics to enhance access to care for expectant mothers. Its innovative solution enables obstetricians to more efficiently screen and manage pregnancy complications, empowering women and reducing geographical barriers.

FreeD Group

Series A in 2017
FreeD Group is a technology company based in Lai Chi Kok, Hong Kong, founded in 2015. It specializes in providing a text-based virtual assistant service that offers travel information and concierge services for travelers in Korea and Japan. The company facilitates various travel-related activities, including flight and hotel bookings, trip planning, restaurant reservations, translation, and transportation services, all accessible through popular messaging platforms like WhatsApp and Facebook Messenger. Additionally, FreeD Group develops AI-enabled solutions that enhance customer engagement, retention, and monetization for businesses. By utilizing advanced technologies such as Artificial Intelligence, Big Data, and Machine Learning, the company aims to create innovative, data-driven interactions between consumers and brands. Its partnerships with notable companies, including China Mobile and Samsung, further bolster its market presence.

Synthace

Series A in 2017
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Lootcakes

Pre Seed Round in 2017
Lootcakes Inc. is a New York-based company founded in 2012 that provides an online platform focused on gaming data, particularly for free-to-play games. The platform allows players to consolidate their gaming activity and social engagement across different platforms. By utilizing in-game purchasing and social data, Lootcakes connects high-value players—those who spend money and engage socially with others—to game publishers. This connection is essential as game publishers increasingly rely on these players, who drive revenue and attract new users through their social interactions. Lootcakes aims to empower gamers by helping them unlock the value of their game activity data, enabling them to benefit from their influence within the gaming community.

STEERING AI

Seed Round in 2017
Steering AI Technologies Co. Ltd is a company focused on developing hardware and software solutions for autonomous driving. Founded in 2017 and headquartered in Xi'an, China, it specializes in creating innovative products such as a smart steering box that monitors driver fatigue and an intelligent steering wheel cover that recognizes both steering motion and drivers' physiological features. Additionally, Steering AI offers a vehicle network cloud platform and a big-data management service designed to enhance fleet safety by monitoring driving behaviors. The company's emphasis on wearable technology and intelligent systems aims to provide early warning systems for fatigue driving, thereby ensuring the safety of drivers on the road.

BoosterAgro

Angel Round in 2017
BoosterAgro, founded in 2016 and based in Buenos Aires, Argentina, is a leading digital platform for agricultural producers in South America. The company provides an app that helps farmers make informed decisions by offering tools and content related to weather forecasts, precipitation, crop health, satellite imagery, smart spraying, and seasonal insights. With over 80,000 users across major agricultural countries including Argentina, Brazil, Uruguay, Paraguay, and Bolivia, BoosterAgro serves as a vital resource for farmers seeking to enhance efficiency and productivity. The platform allows users to access valuable information on demand via mobile devices and also facilitates direct connections between farmers and local suppliers, ensuring that users can easily find products and services tailored to their specific farming needs.

CITYDATA.ai

Seed Round in 2017
CITYDATA.ai is a geospatial AI company that simulates the presence and movement of people across cities worldwide by building mobility digital replicas to quantify how many people are present and how they move. By aggregating location intelligence from public and private sources, it enables cities and businesses to gain actionable insights for planning and operations. The platform supports resident engagement through mobile apps and chatbots and offers a suite of data and tooling products, including CITYSIM, CITYFLOW, CITYPARKS, CITYCOUNT, CITYOPS, CITYSURVEY, CITYCHAT, and CITYSDK, to support city planning, mobility analysis, park management, survey collection, and field workforce productivity.

LotaData

Convertible Note in 2017
Founded in 2014, LotaData specializes in developing mobile location insights and predictive analytics solutions. Its platform analyzes public and private data to provide deep insights about city facilities usage, community demographics, and attendance for events and activities. Serving enterprise businesses, smart cities, and other stakeholders globally, LotaData operates from offices in San Francisco, London, and Porto Alegre.

Bloomlife

Seed Round in 2016
Bloomlife is a pioneering company in maternal health, leveraging connected devices and cloud-based data analytics to enhance access to care for expectant mothers. Its innovative solution enables obstetricians to more efficiently screen and manage pregnancy complications, empowering women and reducing geographical barriers.

Girihlet

Seed Round in 2016
Founded in 2012, Girihlet is a biotechnology company based in Oakland, California. It specializes in accurate profiling of T cell receptor repertoires using innovative sequencing technologies, aiming to advance understanding and management of immune system-related disorders.

Truust Neuroimaging

Seed Round in 2015
Founded in 2015, Truust Neuroimaging specializes in enhancing neuro-imaging systems' resolution at a fraction of the cost of equivalent hardware. This advancement enables breakthroughs in brain research, clinical diagnosis, and treatment of conditions like epilepsy, Alzheimer's, and Parkinson's.

Girihlet

Pre Seed Round in 2015
Founded in 2012, Girihlet is a biotechnology company based in Oakland, California. It specializes in accurate profiling of T cell receptor repertoires using innovative sequencing technologies, aiming to advance understanding and management of immune system-related disorders.

Robin8

Seed Round in 2015
Robin8 is an AI-powered social and content marketing platform that simplifies PR outreach. It curates a database of influencers using machine learning and big data, personalizing results based on user preferences.

Synthace

Series A in 2014
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Darma

Pre Seed Round in 2014
Darma Inc. is a health technology company based in the United States that specializes in non-invasive health monitoring solutions. The company has developed an innovative non-wearable health tracking device known as the DARMA cushion, which allows users to monitor their vital signs through an integrated application while seated. This cushion not only provides real-time data on stress levels, sitting time, and posture but also offers reminders and alerts to encourage users to stand up and improve their posture. Additionally, Darma's technology includes advanced fiber optic biosensors designed for placement under mattresses, facilitating continuous monitoring of vital signs and cardiac performance without direct contact. By combining bio-sensing technology with cloud-based algorithms and healthcare management services, Darma aims to assist patients, caregivers, and healthcare providers in proactive health management, reducing hospital readmissions, and enhancing overall quality of life.

Darma

Pre Seed Round in 2014
Darma Inc. is a health technology company based in the United States that specializes in non-invasive health monitoring solutions. The company has developed an innovative non-wearable health tracking device known as the DARMA cushion, which allows users to monitor their vital signs through an integrated application while seated. This cushion not only provides real-time data on stress levels, sitting time, and posture but also offers reminders and alerts to encourage users to stand up and improve their posture. Additionally, Darma's technology includes advanced fiber optic biosensors designed for placement under mattresses, facilitating continuous monitoring of vital signs and cardiac performance without direct contact. By combining bio-sensing technology with cloud-based algorithms and healthcare management services, Darma aims to assist patients, caregivers, and healthcare providers in proactive health management, reducing hospital readmissions, and enhancing overall quality of life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.